• Journal of Periodontal and Implant Science
• /
• 제52권6호
• /
• pp.437-454
• /
• 2022

Embryonic stem cells have been a popular research topic in regenerative medicine owing to their pluripotency and applicability. However, due to the difficulty in harvesting them and their low yield efficiency, advanced cell reprogramming technology has been introduced as an alternative. Dental stem cells have entered the spotlight due to their regenerative potential and their ability to be obtained from biological waste generated after dental treatment. Cell reprogramming, a process of reverting mature somatic cells into stem cells, and transdifferentiation, a direct conversion between different cell types without induction of a pluripotent state, have helped overcome the shortcomings of stem cells and raised interest in their regenerative potential. Furthermore, the potential of these cells to return to their original cell types due to their epigenetic memory has reinforced the need to control the epigenetic background for successful management of cellular differentiation. Herein, we discuss all available sources of dental stem cells, the procedures used to obtain these cells, and their ability to differentiate into the desired cells. We also introduce the concepts of cell reprogramming and transdifferentiation in terms of genetics and epigenetics, including DNA methylation, histone modification, and non-coding RNA. Finally, we discuss a novel therapeutic avenue for using dental-derived cells as stem cells, and explain cell reprogramming and transdifferentiation, which are used in regenerative medicine and tissue engineering.

• BMB Reports
• /
• 제45권1호
• /
• pp.51-56
• /
• 2012

The purpose of this study was to determine the effects of duration and timing of glucocorticoid treatment on the expansion and differentiation of porcine neonatal pancreas cell clusters (NPCCs) into ${\beta}$-cells. After transplantation of NPCCs, the ductal cyst area and ${\beta}$-cell mass in the grafts both showed positive and negative correlations with duration of dexamethasone (Dx) treatment. Pdx-1 and HNF-3${\beta}$ gene expression was significantly downregulated following Dx treatment, whereas PGC-1${\alpha}$ expression increased. Pancreatic duct cell apoptosis significantly increased following Dx treatment, whereas proliferation did not change. Altogether, transdifferentiation of porcine NPCCs into ${\beta}$-cells was influenced by the duration of Dx treatment, which might have been due to the suppression of key pancreatic transcription factors. PGC-1${\alpha}$ plays an important role in the expansion and transdifferentiation of porcine NPCCs, and the initial 2 weeks following transplantation of porcine NPCCs is a critical period in determining the final ${\beta}$-cell mass in grafts.

• Molecules and Cells
• /
• 제24권3호
• /
• pp.441-444
• /
• 2007

Despite the importance of cell fate decisions regulated by epigenetic programming, no experimental model has been available to study transdifferentiation from myoblasts to smooth muscle cells. In the present study, we show that myoblast cells can be induced to transdifferentiate into smooth muscle cells by modulating their epigenetic programming. The DNA methylation inhibitor, zubularine, induced the morphological transformation of C2C12 myoblasts into smooth muscle cells accompanied by de novo synthesis of smooth muscle markers such as smooth muscle ${\alpha}$-actin and transgelin. Furthermore, an increase of p21 and decrease of cyclinD1 mRNA were observed following zebularine treatment, pointing to inhibition of cell cycle progression. This system may provide a useful model for studying the early stages of smooth muscle cell differentiation.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권4호
• /
• pp.1967-1971
• /
• 2016

Background: In tumor cells, aberrant differentiation programs have been described. Several neuronal proteins have been found associated with morphological neuronal-glial changes in breast cancer (BCa). These neuronal proteins have been related to mechanisms that are involved in carcinogenesis; however, this regulation is not well understood. Microtubule-associated protein-tau (MAP-Tau) has been describing in BCa but not its variants. This finding could partly explain the neuronal-glial morphology of BCa cells. Our aim was to determine mRNA expression of MAP-tau variants 2, 4 and 6 in breast cancer cell lines. Materials and Methods: Cultured cell lines MCF-10A, MDA-MB-231, SKBR3 and T47D were observed under phase-contrast microscopy for neural morphology and analyzed for gene expression of MAP-Tau transcript variants 2, 4 and 6 by real-time PCR. Results: Regarding morphology like neural/glial cells, T47D line shown more cells with these features than MDA-MB-231 and SKBR. In another hand, we found much greater mRNA expression of MAP-Tau transcript variants 2, and to a lesser extent 4 and 6, in T47D cells than the other lines. In conclusion, regulation of MAP-Tau could bring about changes in cytoskeleton, cell morphology and motility; these findings cast further light on neuronal transdifferentiation in BCa.

• Asian-Australasian Journal of Animal Sciences
• /
• 제22권10호
• /
• pp.1447-1460
• /
• 2009

Myogenic satellite cells have been isolated and identified by several recently elucidated molecular markers. Furthermore, knowledge about the precise function of these markers has provided insight into the early and terminal events of satellite cells during proliferation, differentiation, transdifferentiation, specification and activation. Recently, quiescent myogenic satellite cells have been associated with possession of Pax 3 and 7 that represent pluripotent stem cells capable of differentiating into other lineages. However, the mechanism by which myogenic satellite cells attain pluripotent potential remain elusive. Later, transdifferentiating ability of these cells to another lineage in the absence or presence of certain growth factor/ or agents has revolutionized the scope of these pluripotent myogenic satellite cells for manipulation of animal production (in terms of quality and quantity of muscle protein) and health (in terms of repair of skeletal muscle, cartilage or bone).

• 생명과학회지
• /
• 제30권4호
• /
• pp.394-401
• /
• 2020

배아줄기세포는 만능세포이기 때문에 동물에게 주입되면 종양으로 발달할 수도 있다. 따라서 연구자들은 종양 형성으로부터 비교적 자유로운 성체세포로부터 세포 특이적 줄기세포(성체줄기세포)를 확보하는데 관심을 두고 있다. 성체줄기세포는 제한적으로 세포분열을 할 수 있고 지정된 특정 세포로만 발달할 수 있다. 포유동물에서 각 조직의 세포들은 자연적 생리조건하에서는 역분화 혹은 교차분화에 의해 성체줄기세포로 전환되지 않는다. 따라서 일본 연구자들에 의하여 2006년 성체세포의 리프로그램에 의한 유도만능줄기세포(iPSCs) 기술이 소개되어 성체줄기세포 연구의 새로운 장을 열었다. 비록 연구현장에서 iPSCs 기술이 폭 넓게 이용되지만, 리프로그램의 안정성뿐만 아니라 유전체에 외래유전자의 도입 등의 문제점도 있다. Reversine은 iPSCs 보다 2년 앞서 발견된 작은 화학적 합성 분자인 퓨린 유사체이다. Reversine은 분화된 세포를 리프로그램에 의한 역분화를 유도하여 다능성 줄기세포로 전환시킬 수 있으며, 적절한 분화조건하에서 다른 세포로 교차분화를 유도할 수도 있다. 따라서 reversine은 iPSCs가 가지고 있는 문제점을 극복하고 화학적인 방법을 이용하여 성체세포를 다능성 줄기세포로 전환시킬 수 있는 물질로 활용될 수 있다. Reversine이 백색지방세포를 갈색지방형세포(beige cell)로 전변시켜 열발산에 의한 에너지소비를 촉진함을 제시하여 항비만인자로서 그 가능성을 열어 놓았다. Reversine은 세포 역분화의 기능적 역할 이외에 항암 인자로서 또 다른 기능들이 보고되고 있어 앞으로 여러 분야에서 그 이용성이 기대되는 물질이다.

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 The 5th Biannual Meeting of Pacific Rim Society for Fertility and Sterility
• /
• pp.168.2-168.2
• /
• 2006

• 생명과학회지
• /
• 제22권10호
• /
• pp.1316-1323
• /
• 2012

본 연구는 한우유래 myoblast에서 지방세포분화 유도 전사인자들을 과발현시켜 지방세포로의 교차분화를 유도하기 위하여 실시하였다. 한우 유래 satellite cell을 배양한 후 adipogenic transcription factor인 $PPAR{\gamma}$, C/$EBP{\alpha}$, SREBP1c, KLF5등을 단독 또는 co-transfection을 실시하여 세포에 과발현을 유도하였다. 이들 세포들은 adipogenic differentiation medium에서 2일간 배양한 후growth medium에서 8일간 추가로 배양하였다. 지방세포로의 교차분화 유무는 Oil-red O염색과 지방세포 마커 유전자들의 발현으로 확인하였다. $PPAR{\gamma}$과 C/$EBP{\alpha}$를 각각 단독으로 과발현을 유도한 경우myoblast에서 지방세포로의 교차분화를 유도하기에는 충분하지 못하였다. 그러나 $PPAR{\gamma}$와 C/$EBP{\alpha}$을 co-transfection을 실시한 경우 지방세포로의 교차분화가 유도되었고, 세포내지방구형성, 지방세포 마커유전자의 발현, 근세포 마커유전자의 발현 감소 등이 확인되었다. KLF5 와 $PPAR{\gamma}$를 동시에 과발현할 경우 지방세포로의 교차분화를 볼 수 있었지만 KLF단독의 경우는 교차분화를 유도하지 못하였다. 할성형SREBP1c (tSREBP1c)의 경우, 단독으로 myoblast에 과발현을 처리한 경우만으로 지방세포로의 교차분화를 유도할 수 있었다. 이들 결과는 한우유래 satellite cell을 이용하여 지방세포분화 전사인자를 단독 혹은 조합하여 이들 세포에 과발현 시킬 경우 지방세포로의 교차분화를 유도할 수 있음을 보여 주었다.

• 한국수정란이식학회:학술대회논문집
• /
• 한국수정란이식학회 2003년도 제3회 발생공학 국제심포지움 및 학술대회
• /
• pp.71-71
• /
• 2003

• Archives of Pharmacal Research
• /
• 제19권1호
• /
• pp.36-40
• /
• 1996

The effect of glycyrrhetinic acid(18.betha.-glycyrrhetinic acid, GA) on histamine synthesis and release was investigated in cocultured mast cells with Swiss 3T3 fibroblasts. GA has strong dose dependent inhibitory activity for histamine synthesis and release in cocultured mast cells. GA(50 .mu.M) inhibited about 85% of histidine decarboxylase (HDC) activity. The appearance of cells staining positively with berberine sulface was also decreased in the presence of GA. It indicates that transdifferentiation of cultured mas cells (CMCs) was also inhibited.